Search 33,000+ CME courses
Back

PRIME Education, Inc. (PRIME®)

  • Immunoconjugates

Trop-2 Strategies in TNBC: Navigating an Expanding Therapeutic Landscape

Trop-2-directed antibody-drug conjugates (ADCs) continue to redefine the standard of care for patients with triple-negative disease. Test your clinical skills in this interactive case-based activity that explores the nuances of integrating these therapies into real-world practice, focusing on the critical balance between clinical efficacy and patient-centered care. By navigating clinical decisions within this case simulation, you will: Apply recent clinical findings to real-world scenarios to enhance patient-centered treatment decision-making Develop tailored treatment plans based on patient-specific factors Incorporate practical strategies to prevent and manage treatment-related adverse events Receive real-time expert feedback and benchmark your performance against your peers. Upon completion, you will gain access to concise clinical pearls and evidence-based summaries that support optimized treatment selection and improved patient care.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Free

Reported to ACCME by the provider

  • Virtual patient / simulation
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    May 27, 2026
  • Last day to claim credit
    May 27, 2027 8 months left

More from PRIME Education, Inc. (PRIME®)

See all

This provider’s courses closest to this one

Related courses

See all

Other providers’ courses on the same topic